From Bloodstream to Solid Tumors: A Breakthrough Boost for CAR T Cell Therapy
Chimeric Antigen Receptor (CAR) T cell therapies have heralded a new era in oncological treatment, yielding transformative outcomes particularly in hematologic malignancies. These immunotherapies engineer...
















